Skip to content

To see the effect of NavakGuggulu along with Thyroxin in Hypothyroidism

Randomized Controlled Clinical Trial To Evaluate The Add On Effect Of Navaka Guggulu Along With Thyroxine In Hypothyroidism - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076456
Enrollment
66
Registered
2024-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E018- Other iodine-deficiency related thyroid disorders and allied conditions

Interventions

None listed

Sponsors

Dr Revati Pradeep Dhawadkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 2) Known case of Hypothyroidism. 3) Gender - both male and female patients will be selected irrespective of religions and economical status.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from co-morbid or life threatening eliments. 2.Congenital hypothyroidism or anatomical deformity related to thyroid gland 3.Known case of thyroid neoplasia. 4.Progressive case of myxoedema coma. 5.Infiltrative disorders like sarcoidosis etc 6.Individual suffering from immune compromised diseases or patients on immunocompressive drugs. 7.Pregnancy

Design outcomes

Primary

MeasureTime frame
1Weight gain/month 2Amennorrhea 3Loss of appetite 4Constipation 5 Hoarseness of voice 6Somnolence (Duration of sleep) 7Dyspnoea 8Quantity of menstrual flow 9Duration of menstrual bleeding 10Debility 11Dryness of skin 12Hair loss 13. Thyroid Function testTimepoint: Inclusion day, 30th day, 60th day, 90th day.

Secondary

MeasureTime frame
Adverse effect of the Ayurvedic drug if any.Timepoint: Inclusion day, 30th day, 60th day, 90th day.

Countries

India

Contacts

Public ContactDr Vijayalaxmi Sujay Patil

Mams Sumatibhai Shah Ayurved Cllege Hadapsar Pune

drvrmane@gmail.com9665429186

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026